Clinical trial
Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients…
NCT00006024 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00006024 |
|---|---|
| Title | Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma |
| Official title | A Phase I Study of Temozolomide and CCNU in Pediatric Patients With Newly Diagnosed Incompletely Resected Non-Brainstem High-Grade Gliomas |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain Tumor, Central Nervous System Tumor |
| Intervention type | Drug |
| Interventions | lomustine, temozolomide |
| Enrollment | 32 |
| Start date | Nov 1, 2000 |
| Primary completion | Jan 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 13, 2014 |
| Countries | Australia, Canada, Netherlands, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: